885484-41-3 Usage
Uses
Used in Pharmaceutical Industry:
N-(12-Aminododecyl)-1-deoxynojirimycin is used as a glycosidase inhibitor for the preparation of imino-alditols. Its ability to inhibit glycosidase enzymes plays a crucial role in the development of potential therapeutic agents for the treatment of various diseases, such as lysosomal storage disorders and diabetes.
Used in Chemical Research:
As a deoxynojirimycin derivative, N-(12-Aminododecyl)-1-deoxynojirimycin serves as a valuable compound in chemical research, particularly in the field of carbohydrate chemistry and glycobiology. Its unique structure and properties allow scientists to explore its potential applications in the design and synthesis of new bioactive molecules and drug candidates.
Used in Drug Development:
N-(12-Aminododecyl)-1-deoxynojirimycin is utilized in drug development as a lead compound for the creation of novel therapeutic agents. Its glycosidase inhibitory activity and unique structural features make it a promising candidate for the development of drugs targeting various diseases, including metabolic disorders and cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 885484-41-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,4,8 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 885484-41:
(8*8)+(7*8)+(6*5)+(5*4)+(4*8)+(3*4)+(2*4)+(1*1)=223
223 % 10 = 3
So 885484-41-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H38N2O4/c19-11-9-7-5-3-1-2-4-6-8-10-12-20-13-16(22)18(24)17(23)15(20)14-21/h15-18,21-24H,1-14,19H2/t15?,16?,17-,18-/m1/s1
885484-41-3Relevant academic research and scientific papers
Greimel, Peter,Haeusler, Herwig,Lundt, Inge,Rupitz, Karen,Stuetz, Arnold E.,Tarling, Chris A.,Withers, Stephen G.,Wrodnigg, Tanja M.
, p. 2067 - 2070 (2006)
1,5-Dideoxy-1,5-iminoalditols of various configurations as well as isofagomine were N-alkylated with non-polar straight chain spacer-arms by a set of simple standard procedures. The spacer-arms' terminal functional groups, primary amines, were employed to
GLYCOSIDASE-INHIBITING IMINOSUGARS
-
Page/Page column 7-8, (2008/06/13)
The present invention relates to powerful glycosidase-inhibiting iminosugar derivates, preferably iminoalditol derivatives, which bear a marker, preferably a fluorescent moiety, at the ring nitrogen. They are reversible inhibitors and can efficiently be employed as affinity ligands in glycosidase isolation and purification protocols.
